India is moving ahead with plans to ban the sale of branded generics in the country, adding to marketplace concerns …

In a radical change to its modus operandi, NICE has published the first in an ongoing series of assessments of …

Johnson & Johnson has reported a 6.5% year-on-year sales increase to $17.1 billion in the third quarter of 2012, a …

Sir David Nicholson, chief executive of the NHS, has warned that reform of the NHS could end in ‘misery and …
Edelman the world’s largest PR firm has appointed Camilla Horwood to a new role as UK head of Health Public …

Paul Jacobs has joined digital and social agency Sonic Boom Creative Media, a sister agency of AXON Communications, as director, …

The issue of gender balance within UK boards has moved quickly up the business agenda following last year’s Davies Report. …

Roche’s sales for January to September this year were up 4% on the same nine-month period in 2011, with oncology …

GlaxoSmithKline has reversed its earlier plan to close a manufacturing plant in Sligo, Ireland, and says it now intends to …

Teva Pharmaceutical Industries has officially opened its new plant in GödöllÅ‘, Hungary, for the production of sterile injectable pharmaceuticals. The …
Ark wins contract to make gene therapy, Encap starts hot melt extrusion project, plus updates from Reciharm, Symbiosis and Applikon …

Merck has gained access to AiCuris’ portfolio of investigational medicines targeting human cytomegalovirus (HCMV) via a global licensing agreement. It …
A round-up of news in the contract research sector, including new contracts for Medpace, Particle Sciences and PRC Clinical, another …

The MSI Consultancy firm has made changes to its organisational structure with Michael Craig and Dan Heapy being promoted to …

Novartis’ multiple sclerosis (MS) drug Gilenya has demonstrated what the manufacturer calls ‘significant’ benefits for patients if used early. Results …

Johnson & Johnson continues to restructure its manufacturing network, expanding production at plants in Puerto Rico whilst setting up a …
BASF says it is planning to open a new production line in India next year that will make catalysts used …

Roche and Eli Lilly are providing drugs free of charge to US investigators conducting a worldwide trial of Alzheimer’s disease …

Woolley Pau Gyro has appointed Andy Jones to the role of creative director. Jones (pictured) was previously deputy creative director …

Boehringer Ingelheim will be delighted with final guidance from NICE recommending that its veteran drug Actilyse be used as early …